Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

EP. 1: Frontline Quadruplet Therapy in NDMM: GRIFFIN and MASTER Studies

May 10th 2022

Expert perspectives on frontline daratumumab-containing quadruplet regimens in the context of recent clinical trials in newly diagnosed multiple myeloma.

EP. 2: Frontline Quadruplet Therapy in NDMM: GMMG-HD7

May 10th 2022

Shared insight on the GMMG-HD7 study, which utilized a frontline isatuximab-containing quadruplet regimen in patients with newly diagnosed multiple myeloma.

EP. 3: NDMM Management: Assessing Response and Determining Duration of Therapy

May 17th 2022

Comprehensive insight on optimizing newly diagnosed multiple myeloma management, ranging from response assessment to use of consolidation and maintenance therapy.

EP. 4: Case Presentation 1: Selecting Therapy in Transplant-Ineligible NDMM

May 17th 2022

Centering discussion on a patient case of transplant-ineligible newly diagnosed multiple myeloma, experts consider how they would approach workup and management.

EP. 5: Role for Transplantation and Maintenance Therapy in NDMM

May 24th 2022

Considerations for assessing eligibility of patients for transplantation for NDMM and how maintenance therapy may be initiated in the post-transplant setting.

EP. 6: Case Presentation 2: Transplant-Ineligible NDMM and Treatment With the DRd Regimen

May 24th 2022

Experts review a second patient case wherein transplant-ineligible newly diagnosed multiple myeloma was treated with the daratumumab, lenalidomide and dexamethasone regimen and how updated data from the MAIA trial can be incorporated into clinical practice.

EP. 7: Considerations for Incorporating Daratumumab-Containing Regimens in NDMM

May 31st 2022

Shared insight on optimizing selection and use of daratumumab-containing regimens in NDMM, with regard for clinical trial readouts in this setting.

EP. 8: Case Presentation 3: Managing NDMM in Frail Patients

May 31st 2022

Moving to the last patient case of newly diagnosed multiple myeloma, expert panelists work together to define patient frailty in this setting and discuss how frail patients are treated in practice.

EP. 9: Selecting and Sequencing Therapy in Relapsed/Refractory MM

June 7th 2022

Panelists take a broad look at treatment selection and sequencing through multiple lines of therapy in patients with multiple myeloma.

EP. 10: Bispecifics and CAR-T Therapies in the Management of Multiple Myeloma

June 7th 2022

Broad discussion on novel therapies, including bispecifics and CAR-T therapies, that are evolving the treatment landscape of multiple myeloma.